As of December 2024, Interpace Diagnostics Group has a market cap of $12.27M. This makes Interpace Diagnostics Group the world's 29633th valuable company by market cap, according to our data. The market capitalization, also known as a stock market cap is a key financial indication. It represents the combined worth of all the outstanding shares of a publicly traded company multiplied by the current stock price. This figure is often used to see how much a company is worth. This figure is often used to see what is the company net worth.
Year | Market Cap | Change |
---|---|---|
2024 | $4.32M | -7.41% |
2023 | $4.67M | 3.85% |
2022 | $4.49M | -86.08% |
2021 | $32.28M | 137.90% |
2020 | $13.57M | -37.20% |
2019 | $21.61M | -37.50% |
2018 | $34.57M | -21.57% |
2017 | $44.08M | -76.82% |
2016 | $190.16M | -5.38% |
2015 | $200.96M | -74.02% |
2014 | $773.60M | -62.79% |
2013 | $2.08B | -36.71% |
2012 | $3.28B | 18.38% |
2011 | $2.77B | -39.09% |
2010 | $4.56B | 118.67% |
2009 | $2.08B | 20.20% |
2008 | $1.73B | -57.20% |
2007 | $4.05B | -7.68% |
2006 | $4.39B | -24.81% |
2005 | $5.83B | -39.41% |
2004 | $9.63B | -16.90% |
2003 | $11.59B | 148.45% |
2002 | $4.66B | -51.65% |
2001 | $9.65B | -78.89% |
2000 | $45.70B | 3432.30% |
1999 | $1.29B | 5.98% |
1998 | $1.22B | - |